Correction: Ban-Cucerzan et al. Bovine Mastitis Therapy at a Crossroads: Pharmacokinetic Barriers, Biofilms, Antimicrobial Resistance, and Emerging Solutions. Pharmaceuticals 2026, 19, 175

Ban-Cucerzan, Alexandra; Morar, Adriana; Tîrziu, Emil; Bucur, Iulia-Maria; Popa, Sebastian-Alexandru; Imre, Kálmán

doi:10.3390/ph19030446

Open AccessCorrection

Correction: Ban-Cucerzan et al. Bovine Mastitis Therapy at a Crossroads: Pharmacokinetic Barriers, Biofilms, Antimicrobial Resistance, and Emerging Solutions. Pharmaceuticals 2026, 19, 175

by

Alexandra Ban-Cucerzan

^1,2,*

,

Adriana Morar

^1,2,*

,

Emil Tîrziu

^1,2,

Iulia-Maria Bucur

¹

,

Sebastian-Alexandru Popa

^1,2

and

Kálmán Imre

^1,2

¹

Faculty of Veterinary Medicine, University of Life Sciences “King Mihai I” from Timisoara, 300645 Timisoara, Romania

²

Research Institute for Biosecurity and Bioengineering, University of Life Sciences “King Mihai I” from Timisoara, 300645 Timisoara, Romania

^*

Authors to whom correspondence should be addressed.

Pharmaceuticals 2026, 19(3), 446; https://doi.org/10.3390/ph19030446

Submission received: 19 February 2026 / Accepted: 27 February 2026 / Published: 10 March 2026

(This article belongs to the Special Issue Antibiotic Resistance and Misuse)

Download Versions Notes

In the original publication [1], the information on references [5,28,29,30,35,71,74,94,105,135,137,138,139,164,177,227,232] is not correct. The updated versions are as follows:

5.: Velasco Garcia, W.J.; Araripe Dos Santos Neto, N.; Borba Rios, T.; Rocha Maximiano, M.; Souza, C.M.D.; Franco, O.L. Genetic basis of antibiotic resistance in bovine mastitis and its possible implications for human and ecological health. Crit. Rev. Microbiol. 2025, 51, 427–440. https://doi.org/10.1080/1040841x.2024.2369140.
28.: Abd El-Razik, K.A.; Soror, A.H.; Sedky, D.; Fouad, E.A.; Arafa, A.A. Detection of methicillin-resistant Staphylococcus aureus (MRSA) from bovine subclinical mastitis in Egypt using real-time PCR. Int. J. Vet. Sci. 2024, 14, 188–195. https://doi.org/10.47278/journal.ijvs/2024.215.
29.: Hayajneh, F.M.F.; Ahmed, Z.; Khatoon, A.; Saleemi, M.K.; Arshad, M.I.; Gul, S.T. Epidemiological investigations of Mycoplasma bovis—Associated mastitis in dairy animals along with analysis of interleukin-6 (IL-6) as a potential diagnostic marker. Int. J. Vet. Sci. 2023, 13, 120–126. https://doi.org/10.47278/journal.ijvs/2023.072.
30.: Petzl, W.; Zerbe, H.; Günther, J.; Seyfert, H.-M.; Hussen, J.; Schuberth, H.-J. Pathogen-specific responses in the bovine udder. Models and immunoprophylactic concepts. Res. Vet. Sci. 2018, 116, 55–61. https://doi.org/10.1016/j.rvsc.2017.12.012.
35.: Xiao, X.; Chen, X.; Yan, K.; Jiang, L.; Li, R.; Liu, Y.; Wang, M.; Wang, Z. PK/PD integration and pharmacodynamic cutoff of cefquinome against cow mastitis due to Escherichia coli. J. Vet. Pharmacol. Ther. 2022, 45, 83–91. https://doi.org/10.1111/jvp.13012.
71.: Nery Garcia, B.L.; Dantas, S.T.A.; Da Silva Barbosa, K.; Mendes Mitsunaga, T.; Butters, A.; Camargo, C.H.; Nobrega, D.B. Extended-spectrum beta-lactamase-producing Escherichia coli and other antimicrobial-resistant Gram-negative pathogens isolated from bovine mastitis: A One Health Perspective. Antibiotics 2024, 13, 391. https://doi.org/10.3390/antibiotics13050391.
74.: Campos, F.C.; Castilho, I.G.; Rossi, B.F.; Bonsaglia, É.C.R.; Dantas, S.T.A.; Dias, R.C.B.; Fernandes Júnior, A.; Hernandes, R.T.; Camargo, C.H.; Ribeiro, M.G.; et al. Genetic and antimicrobial resistance profiles of mammary pathogenic E. coli (MPEC) isolates from bovine clinical mastitis. Pathogens 2022, 11, 1435. https://doi.org/10.3390/pathogens11121435.
94.: Arefin, M.S.; Mitu, M.J.; Mitu, S.Y.; Nurjahan, A.; Mobin, M.; Nahar, S.; Anjum, H.; Rahman, M.H. Mutational alterations in the QRDR regions associated with fluoroquinolone resistance in Pseudomonas aeruginosa of clinical origin from Savar, Dhaka. PLoS ONE 2025, 20, e0302352. https://doi.org/10.1371/journal.pone.0302352.
105.: Lotfian, Z.; Nave, H.; Khalili, R.; Saffari, F. Contribution of efflux activity in resistance to antibiotics in Escherichia coli clinical isolates. J. Infect. Chemother. 2025, 31, 102725. https://doi.org/10.1016/j.jiac.2025.102725.
135.: Thomas, V.; de Jong, A.; Moyaert, H.; Simjee, S.; El Garch, F.; Morrissey, I.; Marion, H.; Vallé, M. Antimicrobial susceptibility monitoring of mastitis pathogens isolated from acute cases of clinical mastitis in dairy cows across Europe: VetPath results. Int. J. Antimicrob. Agents 2015, 46, 13–20. https://doi.org/10.1016/j.ijantimicag.2015.03.013.
137.: Monistero, V.; Barberio, A.; Cremonesi, P.; Castiglioni, B.; Morandi, S.; Lassen, D.C.K.; Astrup, L.B.; Locatelli, C.; Piccinini, R.; Addis, M.F.; et al. Genotyping and antimicrobial susceptibility profiling of Streptococcus uberis Isolated from a clinical bovine mastitis outbreak in a dairy farm. Antibiotics 2021, 10, 644. https://doi.org/10.3390/antibiotics10060644.
138.: Dego, O.K.; Vidlund, J. Staphylococcal mastitis in dairy cows. Front. Vet. Sci. 2024, 11, 1356259. https://doi.org/10.3389/fvets.2024.1356259.
139.: Majumder, S.; Sackey, T.; Viau, C.; Park, S.; Xia, J.; Ronholm, J.; George, S. Genomic and phenotypic profiling of Staphylococcus aureus isolates from bovine mastitis for antibiotic resistance and intestinal infectivity. BMC Microbiol. 2023, 23, 43. https://doi.org/10.1186/s12866-023-02785-1.
164.: Moreira, G.; Pinho, L.; Mesquita, J.R.; Silva, E. Serratia marcescens isolates from bovine mastitic milk: antimicrobial resistance and virulence features. Antibiotics 2025, 14, 892. https://doi.org/10.3390/antibiotics14090892.
177.: Debruyn, E.; Ghumman, N.; Peng, J.; Tiwari, H.; Gogoi-Tiwari, J. Alternative approaches for bovine mastitis treatment: A critical review of emerging strategies, their effectiveness and limitations. Res. Vet. Sci. 2025, 185, 105557. https://doi.org/10.1016/j.rvsc.2025.105557.
227.: Cordeiro Gomes, F.D.; Ferreira Alves, M.C.; Alves Júnior, S.; Medina, S.H. Bactericidal metal–organic gallium frameworks-synthesis to application. Mol. Pharm. 2025, 22, 638–646. https://doi.org/10.1021/acs.molpharmaceut.4c01253.
232.: Wang, Z.; Wang, J.; Shen, H. Evaluation of the therapeutic effect of a fly maggot antimicrobial peptide in a Staphylococcus aureus-induced mouse mastitis model. Open Vet. J. 2025, 15, 2540–2550. https://doi.org/10.5455/ovj.2025.v15.i6.26.

The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

Ban-Cucerzan, A.; Morar, A.; Tîrziu, E.; Bucur, I.-M.; Popa, S.-A.; Imre, K. Bovine Mastitis Therapy at a Crossroads: Pharmacokinetic Barriers, Biofilms, Antimicrobial Resistance, and Emerging Solutions. Pharmaceuticals 2026, 19, 175. [Google Scholar] [CrossRef] [PubMed]

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ban-Cucerzan, A.; Morar, A.; Tîrziu, E.; Bucur, I.-M.; Popa, S.-A.; Imre, K. Correction: Ban-Cucerzan et al. Bovine Mastitis Therapy at a Crossroads: Pharmacokinetic Barriers, Biofilms, Antimicrobial Resistance, and Emerging Solutions. Pharmaceuticals 2026, 19, 175. Pharmaceuticals 2026, 19, 446. https://doi.org/10.3390/ph19030446

AMA Style

Ban-Cucerzan A, Morar A, Tîrziu E, Bucur I-M, Popa S-A, Imre K. Correction: Ban-Cucerzan et al. Bovine Mastitis Therapy at a Crossroads: Pharmacokinetic Barriers, Biofilms, Antimicrobial Resistance, and Emerging Solutions. Pharmaceuticals 2026, 19, 175. Pharmaceuticals. 2026; 19(3):446. https://doi.org/10.3390/ph19030446

Chicago/Turabian Style

Ban-Cucerzan, Alexandra, Adriana Morar, Emil Tîrziu, Iulia-Maria Bucur, Sebastian-Alexandru Popa, and Kálmán Imre. 2026. "Correction: Ban-Cucerzan et al. Bovine Mastitis Therapy at a Crossroads: Pharmacokinetic Barriers, Biofilms, Antimicrobial Resistance, and Emerging Solutions. Pharmaceuticals 2026, 19, 175" Pharmaceuticals 19, no. 3: 446. https://doi.org/10.3390/ph19030446

APA Style

Ban-Cucerzan, A., Morar, A., Tîrziu, E., Bucur, I.-M., Popa, S.-A., & Imre, K. (2026). Correction: Ban-Cucerzan et al. Bovine Mastitis Therapy at a Crossroads: Pharmacokinetic Barriers, Biofilms, Antimicrobial Resistance, and Emerging Solutions. Pharmaceuticals 2026, 19, 175. Pharmaceuticals, 19(3), 446. https://doi.org/10.3390/ph19030446

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Correction: Ban-Cucerzan et al. Bovine Mastitis Therapy at a Crossroads: Pharmacokinetic Barriers, Biofilms, Antimicrobial Resistance, and Emerging Solutions. Pharmaceuticals 2026, 19, 175

Reference

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI